vs

Side-by-side financial comparison of NPK International Inc. (NPKI) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.

OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $75.2M, roughly 2.0× NPK International Inc.). On growth, NPK International Inc. posted the faster year-over-year revenue change (30.7% vs -19.2%). NPK International Inc. produced more free cash flow last quarter ($5.8M vs $-28.6M). Over the past eight quarters, NPK International Inc.'s revenue compounded faster (23.9% CAGR vs -7.5%).

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

NPKI vs OPK — Head-to-Head

Bigger by revenue
OPK
OPK
2.0× larger
OPK
$148.5M
$75.2M
NPKI
Growing faster (revenue YoY)
NPKI
NPKI
+49.9% gap
NPKI
30.7%
-19.2%
OPK
More free cash flow
NPKI
NPKI
$34.3M more FCF
NPKI
$5.8M
$-28.6M
OPK
Faster 2-yr revenue CAGR
NPKI
NPKI
Annualised
NPKI
23.9%
-7.5%
OPK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NPKI
NPKI
OPK
OPK
Revenue
$75.2M
$148.5M
Net Profit
$-31.3M
Gross Margin
37.7%
43.1%
Operating Margin
16.7%
-25.8%
Net Margin
-21.1%
Revenue YoY
30.7%
-19.2%
Net Profit YoY
-322.8%
EPS (diluted)
$0.17
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPKI
NPKI
OPK
OPK
Q4 25
$75.2M
$148.5M
Q3 25
$68.8M
$151.7M
Q2 25
$68.2M
$156.8M
Q1 25
$64.8M
$150.0M
Q4 24
$57.5M
$183.6M
Q3 24
$44.2M
$173.6M
Q2 24
$66.8M
$182.2M
Q1 24
$49.0M
$173.7M
Net Profit
NPKI
NPKI
OPK
OPK
Q4 25
$-31.3M
Q3 25
$5.7M
$21.6M
Q2 25
$8.7M
$-148.4M
Q1 25
$10.0M
$-67.6M
Q4 24
$14.0M
Q3 24
$-174.3M
$24.9M
Q2 24
$8.0M
$-10.3M
Q1 24
$7.3M
$-81.8M
Gross Margin
NPKI
NPKI
OPK
OPK
Q4 25
37.7%
43.1%
Q3 25
31.9%
32.9%
Q2 25
36.9%
31.5%
Q1 25
39.0%
28.4%
Q4 24
39.2%
46.1%
Q3 24
27.5%
23.1%
Q2 24
37.2%
28.4%
Q1 24
36.0%
24.2%
Operating Margin
NPKI
NPKI
OPK
OPK
Q4 25
16.7%
-25.8%
Q3 25
13.2%
31.7%
Q2 25
17.0%
-38.3%
Q1 25
20.9%
-44.8%
Q4 24
20.2%
-18.0%
Q3 24
2.8%
8.2%
Q2 24
18.7%
-33.9%
Q1 24
14.2%
-41.2%
Net Margin
NPKI
NPKI
OPK
OPK
Q4 25
-21.1%
Q3 25
8.2%
14.3%
Q2 25
12.7%
-94.7%
Q1 25
15.4%
-45.1%
Q4 24
7.6%
Q3 24
-394.3%
14.3%
Q2 24
12.0%
-5.7%
Q1 24
14.9%
-47.1%
EPS (diluted)
NPKI
NPKI
OPK
OPK
Q4 25
$0.17
$-0.04
Q3 25
$0.07
$0.03
Q2 25
$0.10
$-0.19
Q1 25
$0.11
$-0.10
Q4 24
$0.10
$0.02
Q3 24
$-1.99
$0.03
Q2 24
$0.09
$-0.01
Q1 24
$0.08
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPKI
NPKI
OPK
OPK
Cash + ST InvestmentsLiquidity on hand
$5.1M
$364.4M
Total DebtLower is stronger
$16.9M
$344.0M
Stockholders' EquityBook value
$351.2M
$1.3B
Total Assets
$441.8M
$1.9B
Debt / EquityLower = less leverage
0.05×
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPKI
NPKI
OPK
OPK
Q4 25
$5.1M
$364.4M
Q3 25
$35.6M
$412.0M
Q2 25
$26.0M
$267.3M
Q1 25
$20.8M
$428.8M
Q4 24
$17.8M
$426.6M
Q3 24
$42.9M
$400.1M
Q2 24
$35.1M
$40.6M
Q1 24
$37.7M
$75.6M
Total Debt
NPKI
NPKI
OPK
OPK
Q4 25
$16.9M
$344.0M
Q3 25
$9.5M
$344.2M
Q2 25
$9.3M
$343.3M
Q1 25
$8.1M
$439.2M
Q4 24
$7.7M
$437.2M
Q3 24
$14.0M
$441.0M
Q2 24
$58.0M
$201.9M
Q1 24
$77.4M
$350.1M
Stockholders' Equity
NPKI
NPKI
OPK
OPK
Q4 25
$351.2M
$1.3B
Q3 25
$333.9M
$1.3B
Q2 25
$328.8M
$1.3B
Q1 25
$326.9M
$1.3B
Q4 24
$326.5M
$1.4B
Q3 24
$316.5M
$1.4B
Q2 24
$426.6M
$1.4B
Q1 24
$421.6M
$1.3B
Total Assets
NPKI
NPKI
OPK
OPK
Q4 25
$441.8M
$1.9B
Q3 25
$404.5M
$2.0B
Q2 25
$393.7M
$2.0B
Q1 25
$390.0M
$2.1B
Q4 24
$393.7M
$2.2B
Q3 24
$389.6M
$2.3B
Q2 24
$624.8M
$2.0B
Q1 24
$640.8M
$2.0B
Debt / Equity
NPKI
NPKI
OPK
OPK
Q4 25
0.05×
0.27×
Q3 25
0.03×
0.26×
Q2 25
0.03×
0.26×
Q1 25
0.02×
0.33×
Q4 24
0.02×
0.32×
Q3 24
0.04×
0.31×
Q2 24
0.14×
0.14×
Q1 24
0.18×
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NPKI
NPKI
OPK
OPK
Operating Cash FlowLast quarter
$18.0M
$-25.9M
Free Cash FlowOCF − Capex
$5.8M
$-28.6M
FCF MarginFCF / Revenue
7.6%
-19.3%
Capex IntensityCapex / Revenue
16.3%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$26.3M
$-190.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NPKI
NPKI
OPK
OPK
Q4 25
$18.0M
$-25.9M
Q3 25
$24.7M
$-34.6M
Q2 25
$21.4M
$-83.4M
Q1 25
$8.8M
$-34.6M
Q4 24
$-4.1M
$-44.4M
Q3 24
$2.8M
$-77.1M
Q2 24
$27.6M
$-26.4M
Q1 24
$11.9M
$-35.6M
Free Cash Flow
NPKI
NPKI
OPK
OPK
Q4 25
$5.8M
$-28.6M
Q3 25
$12.0M
$-37.8M
Q2 25
$9.7M
$-86.7M
Q1 25
$-1.2M
$-37.7M
Q4 24
$-17.7M
$-49.8M
Q3 24
$-6.7M
$-85.0M
Q2 24
$21.0M
$-33.7M
Q1 24
$-1.9M
$-40.0M
FCF Margin
NPKI
NPKI
OPK
OPK
Q4 25
7.6%
-19.3%
Q3 25
17.4%
-24.9%
Q2 25
14.3%
-55.3%
Q1 25
-1.8%
-25.2%
Q4 24
-30.8%
-27.1%
Q3 24
-15.2%
-49.0%
Q2 24
31.4%
-18.5%
Q1 24
-3.9%
-23.0%
Capex Intensity
NPKI
NPKI
OPK
OPK
Q4 25
16.3%
1.8%
Q3 25
18.5%
2.1%
Q2 25
17.1%
2.1%
Q1 25
15.5%
2.1%
Q4 24
23.6%
2.9%
Q3 24
21.4%
4.6%
Q2 24
9.9%
4.0%
Q1 24
28.3%
2.6%
Cash Conversion
NPKI
NPKI
OPK
OPK
Q4 25
Q3 25
4.37×
-1.60×
Q2 25
2.47×
Q1 25
0.88×
Q4 24
-3.17×
Q3 24
-3.10×
Q2 24
3.43×
Q1 24
1.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NPKI
NPKI

Rental Revenue$34.8M46%
Products$25.5M34%
Services$14.9M20%

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

Related Comparisons